(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Authorities Bust Camel Booze Smuggling Operation, Seize Nearly 2,000 Containers of Illegal Alcohol - 2Trump administration launches new immigration crackdowns in New Orleans and Minneapolis. Here are all the cities it has targeted so far.
- 3We may have one thing in common with jellyfish, new research finds
- 4Russia downs 16 drones heading for Moscow, mayor says
- 5Man threatens attack on German high-speed train, 12 lightly injured
- Flu illness count nears 5 million, with New York City among the hardest hit
- Eat Well, Live Well: An Extensive Manual for Smart dieting and Sustenance
- The Effect of Online Organizations on Society: Beating the Difficulties
- The Way to Monetary Health: Individual budget Change
- Palestinian leader Abbas says elections only after Gaza war ends
- Discovering a sense of harmony: Individual Accounts of Reflection and Care
- What we know about Jonathan Ross, the ICE agent who shot and killed Renee Nicole Good in Minneapolis
- Starbucks' new 'Bearista' cup is causing a stir — and is being listed on eBay for $600
- IDF struck Iran's largest petrochemical plant, second facility hit in two days, Katz confirms
